Adaptyv Bio
PrivateLast Round
Series A
Aug 26, 2026
Total Funding Raised
$50.85M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Adaptyv Bio operates in Healthcare & Life Sciences and is based in Epalinges, Vaud. Its latest recorded funding round was a Series A round in August 2026.
Adaptyv Bio is a biotechnology company that develops a next-generation protein engineering foundry integrating artificial intelligence, robotics, and nanofluidics to accelerate the design, synthesis, and testing of novel proteins.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, ML Platforms
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adaptyv Bio Comparables
Compare Adaptyv Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ailurus Biotechnology | 79% | |
| Arctoris | 78% | |
| Tierra Biosciences | 78% |
For institutional investors. Book with your work email.
Adaptyv Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 26, 2026 | ||||
| Seed | Sep 25, 2025 | ||||
| Debt | Jun 1, 2023 | ||||
| Pre Seed | Feb 14, 2022 | ||||
| Seed | Aug 4, 2021 | ||||
Grant | Apr 28, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Adaptyv Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LongGame Ventures | Seed |
| Foundation for Technological Innovation | Debt |
| Acequia Capital | Pre Seed |
| Founders, Inc. | Pre Seed |
| ACE Ventures | Seed |
| Hawktail Management | Pre Seed |
| Rheingau Founders | Pre Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 26, 2026
$40M round led by Highland Europe.
- Apr 18, 2026
Added Cradle, a biotechnology/AI startup, as a customer.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- has_revenueSep 2, 2026
Adaptyv Bio records an estimated $2.6M in revenue in Dec '24.
- receives_financingAug 29, 2026
Adaptyv Bio recently receives a $46.6M Series A led by Highland Europe, with participation from ACE Ventures, byFounders and Y Combinator, to expand its full-stack platform for AI-enabled protein engineering in Switzerland.
- receives_financingAug 27, 2026
Adaptyv Bio raised a $40M Series A on Aug 27th '26 in Switzerland, led by Highland Europe with existing investors Ace Ventures, ByFounders, and Y Combinator, to build an automated lab for AI-driven protein design.
- integrates_withAug 27, 2026
Adaptyv Bio's publicly available API integrates with Boltz and lets AI agents order experiments directly through its automated lab in Aug '26.
- expands_facilitiesAug 27, 2026
Adaptyv Bio announces a facility expansion in Lausanne as it plans to roughly triple its lab capacity by the end of 2026, alongside a new lab and office opening in London in Q4 '26.
For institutional investors. Book with your work email.
Adaptyv Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Adaptyv Bio's valuation, stock price, and market status.
Is Adaptyv Bio a public or private company?
Adaptyv Bio is a private company.
What is the current stock price of Adaptyv Bio?
Adaptyv Bio is a private company, so its shares have no public market price. Caplight tracks Adaptyv Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Adaptyv Bio worth (valuation)?
Valuation information for Adaptyv Bio is not publicly available.
Can I buy Adaptyv Bio stock?
Adaptyv Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Adaptyv Bio's last funding round?
Adaptyv Bio's most recent funding round was Series A on August 26, 2026.
Who are the main investors in Adaptyv Bio?
Key investors in Adaptyv Bio include ACE Ventures, ACE Ventures, Highland Europe, Founderful.
Will Adaptyv Bio IPO soon?
No public IPO plans have been announced for Adaptyv Bio.
How can I track Adaptyv Bio secondary market activity?
Caplight tracks bids, offers, and trades in Adaptyv Bio's shares on secondary markets.